These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 31495127

  • 1. [Efficacy of Hyper-CVAD/MA and CHALL-01 regimens in the treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia patients under 60 years old].
    Huang AJ, Wang LB, Du J, Tang GS, Cheng H, Gong SL, Gao L, Qiu HY, Ni X, Chen J, Chen L, Zhang WP, Wang JM, Yang JM, Hu XX.
    Zhonghua Xue Ye Xue Za Zhi; 2019 Aug 14; 40(8):625-632. PubMed ID: 31495127
    [Abstract] [Full Text] [Related]

  • 2. Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia.
    Faderl S, Kantarjian HM, Thomas DA, Cortes J, Giles F, Pierce S, Albitar M, Estrov Z.
    Leuk Lymphoma; 2000 Jan 14; 36(3-4):263-73. PubMed ID: 10674898
    [Abstract] [Full Text] [Related]

  • 3. Hyper-CVAD Compared With BFM-like Chemotherapy for the Treatment of Adult Acute Lymphoblastic Leukemia. A Retrospective Single-Center Analysis.
    El-Cheikh J, El Dika I, Massoud R, Charafeddine M, Mahfouz R, Kharfan-Dabaja MA, Bazarbachi A.
    Clin Lymphoma Myeloma Leuk; 2017 Mar 14; 17(3):179-185. PubMed ID: 27988194
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effectiveness of modified hyper-CVAD chemotherapy regimen in the treatment of adult acute lymphoblastic leukemia: a retrospective experience.
    Jalaeikhoo H, Rajaeinejad M, Keyhani M, Zokaasadi M, Dehghani Firoozabadi MM.
    Cancer Med; 2018 Mar 14; 7(3):594-599. PubMed ID: 29383863
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) compared to Hyper-CVAD regimen as salvage chemotherapy in relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Liu L, Jiao W, Zhang Y, Qu Q, Li X, Wu D.
    Leuk Res; 2015 Mar 14; 39(3):323-8. PubMed ID: 25638269
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen.
    Weiser MA, O'Brien S, Thomas DA, Pierce SA, Lam TP, Kantarjian HM.
    Cancer; 2002 Jan 15; 94(2):285-91. PubMed ID: 11900213
    [Abstract] [Full Text] [Related]

  • 10. Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia.
    Thomas DA, O'Brien S, Faderl S, Garcia-Manero G, Ferrajoli A, Wierda W, Ravandi F, Verstovsek S, Jorgensen JL, Bueso-Ramos C, Andreeff M, Pierce S, Garris R, Keating MJ, Cortes J, Kantarjian HM.
    J Clin Oncol; 2010 Aug 20; 28(24):3880-9. PubMed ID: 20660823
    [Abstract] [Full Text] [Related]

  • 11. Outcome of patients with chronic myeloid leukemia in lymphoid blastic phase and Philadelphia chromosome-positive acute lymphoblastic leukemia treated with hyper-CVAD and dasatinib.
    Morita K, Kantarjian HM, Sasaki K, Issa GC, Jain N, Konopleva M, Short NJ, Takahashi K, DiNardo CD, Kadia TM, Garcia-Manero G, Daver N, Montalban Bravo G, Cortes JE, Ravandi F, Jabbour E.
    Cancer; 2021 Aug 01; 127(15):2641-2647. PubMed ID: 33823073
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Salvage therapy for children with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Kodama Y, Manabe A, Kawasaki H, Kato I, Kato K, Sato A, Matsumoto K, Kato M, Hiramatsu H, Sano H, Kaneko T, Oda M, Saito AM, Adachi S, Horibe K, Mizutani S, Ishii E, Shimada H.
    Pediatr Blood Cancer; 2017 Aug 01; 64(8):. PubMed ID: 28084041
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single-centre, phase 2 study.
    Jabbour E, Short NJ, Ravandi F, Huang X, Daver N, DiNardo CD, Konopleva M, Pemmaraju N, Wierda W, Garcia-Manero G, Sasaki K, Cortes J, Garris R, Khoury JD, Jorgensen J, Jain N, Alvarez J, O'Brien S, Kantarjian H.
    Lancet Haematol; 2018 Dec 01; 5(12):e618-e627. PubMed ID: 30501869
    [Abstract] [Full Text] [Related]

  • 16. Results of the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen in elderly patients with acute lymphocytic leukemia.
    O'Brien S, Thomas DA, Ravandi F, Faderl S, Pierce S, Kantarjian H.
    Cancer; 2008 Oct 15; 113(8):2097-101. PubMed ID: 18720356
    [Abstract] [Full Text] [Related]

  • 17. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia.
    Kantarjian HM, O'Brien S, Smith TL, Cortes J, Giles FJ, Beran M, Pierce S, Huh Y, Andreeff M, Koller C, Ha CS, Keating MJ, Murphy S, Freireich EJ.
    J Clin Oncol; 2000 Feb 15; 18(3):547-61. PubMed ID: 10653870
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Daver N, Thomas D, Ravandi F, Cortes J, Garris R, Jabbour E, Garcia-Manero G, Borthakur G, Kadia T, Rytting M, Konopleva M, Kantarjian H, O'Brien S.
    Haematologica; 2015 May 15; 100(5):653-61. PubMed ID: 25682595
    [Abstract] [Full Text] [Related]

  • 20. A pilot study of daunorubicin-augmented hyper-CVAD induction chemotherapy for adults with acute lymphoblastic leukemia.
    Kim SY, Park JH, Yoon SY, Cho YH, Lee MH.
    Cancer Chemother Pharmacol; 2018 Feb 15; 81(2):393-398. PubMed ID: 29294168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.